Boundless Bio, Inc.
BOLD
$1.44
-$0.06-4.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -32.22% | -24.43% | -17.75% | -12.78% | -7.70% |
| Total Depreciation and Amortization | 13.48% | 9.27% | 5.21% | 3.42% | 1.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.24% | 20.93% | -39.13% | -48.64% | -46.16% |
| Change in Net Operating Assets | -110.01% | -100.00% | -699.12% | 5.84% | -192.26% |
| Cash from Operations | -29.85% | -25.60% | -27.12% | -19.26% | -18.33% |
| Capital Expenditure | -300.63% | -478.71% | -446.59% | 9.42% | 40.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 37.37% | 78.43% | -37.35% | -205.79% | -318.79% |
| Cash from Investing | 31.78% | 73.50% | -42.45% | -209.32% | -337.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 51,093.41% | 52,202.25% | 68,417.65% | 57.30% | 44.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.22% | -415.43% | -1,408.51% | -- | -- |
| Cash from Financing | -8.25% | -11.07% | -11.94% | 72,515.73% | 77,596.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -77.46% | 133.16% | -137.72% | 215.38% | 154.77% |